Devices › Device types
FDA product code GDY · class 1 · General, Plastic Surgery
Gauze/sponge, internal, x-ray detectable: medical device reports filed with FDA
2,528 reports carry this product code, 1992–2026; 8 brands with a page.
- 2,528
- reports with this product code
- 0% of all MAUDE reports
- 104
- reports, 12 months to August 2026
- 106 in the 12 months before
- 86.7%
- classified as malfunction
- 62.3% across all reports
- 0.1%
- classified as death, as reported
- 0.9% across all reports
Product code GDY is FDA's classification for "Gauze/sponge, internal, x-ray detectable" (general, Plastic Surgery panel), a class 1 device. 2,528 medical device reports carry this product code, 0% of the MAUDE database, from February 1992 to August 2026.
104 reports arrived in the 12 months to August 2026, close to the 106 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (86.7%), injury (8.1%) and other (3.2%). 8 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Situate | 416 | 50 | 0% | 90.1% |
| Vistec | 289 | 29 | 0% | 100% |
| Unknown Instruments Product | 11 | 23 | 0.8% | 80.5% |
| Medline | 4 | 26,184 | 0.1% | 97.9% |
| Curity | 3 | 18 | 0.2% | 92% |
| Covidien | 2 | 30 | 1.4% | 45.5% |
| Deroyal | 2 | 14 | 0.7% | 72.7% |
| Kendall | 1 | 23 | 2.3% | 61.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Covidien | 495 | 19.6% |
| Cardinal Health | 101 | 4% |
| Medline Industries | 61 | 2.4% |
| Cardinal Health 200 | 57 | 2.3% |
| Covidien Mfg Dc Boulder | 38 | 1.5% |
| Stryker Instruments | 26 | 1% |
| Stryker Instruments-Kalamazoo | 14 | 0.6% |
| Argon Medical Devices | 13 | 0.5% |
| Deroyal Industries | 13 | 0.5% |
| Conmed | 3 | 0.1% |
| Stryker Instruments-A Division Of Stryker | 3 | 0.1% |
| Codman & Shurtleff | 1 | 0% |
| Codman And Shurtleff | 1 | 0% |
| Medtronic Xomed | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Material frayed | 563 | 22.3% |
| Material fragmentation | 395 | 15.6% |
| Detachment of device or device componentpart of the device came off | 252 | 10% |
| Material separation | 160 | 6.3% |
| Component missing | 122 | 4.8% |
| Material integrity problema problem with the device material | 115 | 4.5% |
| Incomplete or missing packaging | 103 | 4.1% |
| Packaging problem | 96 | 3.8% |
| Detachment of device component | 80 | 3.2% |
| Device contamination with chemical or other material | 80 | 3.2% |
| Particulates | 55 | 2.2% |
| Material disintegration | 51 | 2% |
| Breakthe device broke | 41 | 1.6% |
| Manufacturing, packaging or shipping problem | 41 | 1.6% |
| Flaked | 39 | 1.5% |
| Device packaging compromised | 32 | 1.3% |
| Foreign material | 32 | 1.3% |
| Component falling | 22 | 0.9% |
| Contamination | 22 | 0.9% |
| Device misassembled during manufacturing /shipping | 20 | 0.8% |
Questions about gauze/sponge, internal, x-ray detectable reports
What is product code GDY?
FDA's classification code for "Gauze/sponge, internal, x-ray detectable", class 1, reviewed by the general, Plastic Surgery panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,528 reports through August 2026, 104 of them in the latest 12 months.
Which brands appear most often?
Situate (416), Vistec (289), Unknown Instruments Product (11), Medline (4) and Curity (3). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.